These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30017389)

  • 1. Leprosy and its reactional episodes: Serum levels and possible roles of omega-3 and omega-6-derived lipid mediators.
    de Macedo CS; de Carvalho FM; Amaral JJ; de Mendonça Ochs S; Assis EF; Sarno EN; Bozza PT; Pessolani MCV
    Cytokine; 2018 Dec; 112():87-94. PubMed ID: 30017389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
    Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyunsaturated Fatty Acid-Derived Lipid Mediators as Potential Biomarkers for Leprosy Among Individuals with Asymptomatic
    Silva CAM; Graham BG; Webb K; Islam MN; Harton M; de Mello Marques MA; Marques de Carvalho F; Pinheiro RO; Spencer J; Sarno EN; Batista Pereira GM; Vidal Pessolani MC; Santos de Macedo C; Belisle JT
    ACS Infect Dis; 2023 Aug; 9(8):1458-1469. PubMed ID: 37428112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and limitations of serodiagnostic tests in monitoring the response to treatment of leprosy patients.
    Duthie MS; Roferos FO; Abellana JF; Taborada T; Sanchez R; Maghanoy A; Balagon MF
    Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114984. PubMed ID: 31954594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
    Vieira AP; Trindade MAB; de Paula FJ; Sakai-Valente NY; Duarte AJDS; Lemos FBC; Benard G
    BMC Infect Dis; 2017 Apr; 17(1):305. PubMed ID: 28438129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
    Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
    PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro thalidomide does not interfere with the activation of complement by M. leprae.
    Shannon EJ; Sandoval FG; Morales MJ
    J Drugs Dermatol; 2011 Mar; 10(3):274-8. PubMed ID: 21369644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.
    Silva CA; Webb K; Andre BG; Marques MA; Carvalho FM; de Macedo CS; Pinheiro RO; Sarno EN; Pessolani MC; Belisle JT
    J Infect Dis; 2017 Feb; 215(3):431-439. PubMed ID: 27932613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of response to WHO/MDT; a case report.
    Habtemariam H; Guebre-Xabier M
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):632-4. PubMed ID: 8151198
    [No Abstract]   [Full Text] [Related]  

  • 15. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M; Saunderson PR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late leprosy reaction presenting as erythema multiforme-like erythema nodosum leprosum with underlying rifampicin resistance and its potential implications.
    Sardana K; Kulhari A; Mathachan SR; Khurana A; Bansal P; Ahuja A; Lavania M; Ahuja M
    Int J Mycobacteriol; 2020; 9(2):226-228. PubMed ID: 32474551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.
    Chaitanya S; Lavania M; Turankar RP; Karri SR; Sengupta U
    J Clin Immunol; 2012 Dec; 32(6):1415-20. PubMed ID: 22847545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.